https://dev.acb2.ccplabs.com/acb-presenting-at-biotech-showcase/2022-05-26T14:35:22+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-announces-cny63m-usd10m-financing-to-advance-its-synthetic-lethal-platform-and-pre-clinical-oncology-pipeline/2022-05-26T14:35:22+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-announces-preclinical-data-of-lead-compounds-against-novel-myc-synthetic-lethal-target-in-cancer/2022-05-26T14:35:01+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-appoints-leader-in-oncology/2022-05-26T14:35:01+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-announces-its-first-granted-us-patent/2022-05-26T14:35:01+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-welcomes-new-investor-into-seed-financing-round-bringing-total-raised-to-over-31m-to-advance-synthetic-lethality-approaches-to-cancer-therapy/2022-05-26T14:35:01+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-has-been-named-as-one-of-the-50-most-admired-companies-of-the-year-2021-by-the-silicon-review/2022-05-26T14:35:01+00:00https://endpts.com/a-synthetic-lethality-player-emerges-in-china-armed-with-lessons-on-undruggable-oncogene-from-nobel-laureates-lab/#new_tab2023-04-28T00:30:51+00:00https://www.thepharmaletter.com/in-brief/brief-anticancer-bioscience-announces-10-million-financing#new_tab2023-04-28T00:29:19+00:00https://www.bioworld.com/articles/503398-chinas-anticancer-bioscience-raises-10-million-aims-high-in-china?v=preview#new_tab2023-04-28T00:28:00+00:00https://www.precisiononcologynews.com/drug-discovery-development/anticancer-bioscience-raises-10m-advance-synthetic-lethality-programs#.YY46NGDP2Ht#new_tab2023-04-28T00:24:29+00:00https://www.drugdiscoverynews.com/synthetic-lethal-drugs-vs-cancer-15095#new_tab2023-04-28T00:22:25+00:00https://pharmaboardroom.com/interviews/dun-yang-president-ceo-anticancer-bioscience/#new_tab2023-04-28T00:19:15+00:00https://www.biocentury.com/article/637032/anticancer-bioscience-applying-synthetic-lethality-to-myc-driven-cancers#new_tab2023-04-28T00:17:24+00:00https://www.fiercebiotech.com/biotech/acb-hires-liu-from-eureka-therapeutics-to-lead-push-into-clinic#new_tab2023-04-28T00:33:39+00:00https://www.biospectrumasia.com/news/39/18591/anticancer-bioscience-appoints-dr-hong-liu-as-us-based-vp-of-clinical-development.html#new_tab2023-02-11T23:44:57+00:00https://www.ddw-online.com/a-mini-library-approach-delivers-an-arsenal-in-the-drug-development-pipeline-12450-202107/#new_tab2023-04-28T00:35:02+00:00https://www.nature.com/articles/d43747-021-00102-1#new_tab2023-04-28T00:38:34+00:00https://thesiliconreview.com/magazine/profile/anticancer-bioscience-developing-breakthrough-cancer-therapies#new_tab2023-04-28T00:04:48+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-expands-its-rd-and-headquarters-with-a-relocation-to-tianfu-international-biotown-china/2022-05-26T14:35:01+00:00https://dev.acb2.ccplabs.com/dr-allen-vp-of-anticancer-bioscience-presented-his-insights-on-personalized-precision-medicine-at-a-roundtable-discussion-organized-by-pharmas-almanac/2022-05-26T14:35:00+00:00https://www.pharmasalmanac.com/articles/q-what-do-you-see-as-the-key-innovations-or-technologies-that-will-make-personalized/precision-medicine-a-reality#new_tab2023-04-28T00:37:14+00:00https://www.pharmasalmanac.com/articles/q-for-what-therapeutic-area-do-you-think-we-will-see-the-greatest-progress-in-the-coming-years#new_tab2023-04-28T00:37:40+00:00https://www.lsxleaders.com/female-founders/resources/interview-interview-jing-zhang#new_tab2023-04-28T00:41:37+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-identified-phytochemical-corynoline-as-a-prototype-structure-for-developing-centrosome-declustering-therapeutics/2022-05-26T14:35:00+00:00https://dev.acb2.ccplabs.com/anticancer-biosciences-ceo-and-founder-dr-dun-yang-named-as-a-2022-in-vivo-rising-leader/2022-05-26T14:35:00+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-and-delsitech-announce-a-collaboration-agreement-for-the-development-of-long-acting-and-controlled-release-therapies-in-oncology/2022-05-26T14:35:00+00:00https://invivo.pharmaintelligence.informa.com/IV146636/From-Chengdu-To-The-World-Anticancer-Takes-Novel-Approach-To-Cancer-Drug-Development#new_tab2023-04-28T00:40:22+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-named-a-finalist-for-china-biopharma-leadership-award-by-scrip/2022-09-23T16:14:58+00:00https://www.biospectrumasia.com/opinion/98/21899/we-need-to-foster-risky-projects-that-can-have-large-rewards.html#new_tab2023-04-28T00:01:52+00:00https://globalbusinessleadersmag.com/anticancer-bioscience-facilitating-cancer-treatment/#new_tab2023-04-28T00:40:02+00:00https://www.science.org/content/resource/myc-drop-synthetic-lethal-drugs-are-targeting-common-cancer-culprit#new_tab2023-12-11T09:43:25+00:00https://dev.acb2.ccplabs.com/anticancer-bioscience-unveils-groundbreaking-myc-synthetic-lethal-therapy-at-aacr-2024/2024-04-14T12:26:31+00:00